menu search

10x genomics: unveiling the investment potential

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenu...

November 4, 2023, 1:02 am

Clorox alert: bragar eagel & squire, p.c. is investigating the clorox company on behalf of clorox stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potent...

November 4, 2023, 1:00 am

Li-cycle alert: bragar eagel & squire, p.c. is investigating li-cycle, corp. on behalf of li-cycle stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potent...

November 4, 2023, 1:00 am

Dollar alert: bragar eagel & squire, p.c. is investigating dollar general corporation on behalf of dollar stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potent...

November 4, 2023, 1:00 am

Docgo alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against docgo, inc. and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that ...

November 4, 2023, 1:00 am

R1 rcm alert: bragar eagel & squire, p.c. is investigating r1 rcm corp. on behalf of r1 rcm stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potent...

November 4, 2023, 1:00 am

Fairfax financial: q3 2023 results indicate banner year ahead

YTD book value per share increased 16.4% before dividends and 15% ex-dividends. YTD gross premiums written up 7.5% with a combined ratio of ~94%. Mana...

November 4, 2023, 12:42 am

Canon isn't picture-perfect

Canon has operational advantages in its printing segment and has a strong global presence in various markets. However, the company's financial metrics...

November 4, 2023, 12:12 am

Seacor marine: good company, but not good enough

The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...

November 4, 2023, 12:05 am

Regal rexnord corporation (rrx) q3 2023 earnings call transcript

Regal Rexnord Corporation (NYSE:RRX ) Q3 2023 Earnings Conference Call November 2, 2023 10:00 AM ET Company Participants Robert Barry – Vice Preside...

November 3, 2023, 11:54 pm

Egain corporation (egan) q1 2024 earnings call transcript

eGain Corporation (NASDAQ:EGAN ) Q1 2024 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jim Byers - MKR IR Ashu Roy - CEO E...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl

This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) — A national youth prevention summit org...

November 3, 2023, 11:10 pm

Vitesse energy, inc. (vts) q3 2023 earnings call transcript

Vitesse Energy, Inc. (NYSE:VTS ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Ben Messier - Director, IR Bob Gerr...

November 3, 2023, 11:03 pm

Aspen aerogels, inc. (aspn) q3 2023 earnings call transcript

Aspen Aerogels, Inc. (NYSE:ASPN ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Neal Baranosky – Senior Director...

November 3, 2023, 11:01 pm

Advanced drainage systems, inc. (wms) q2 2024 earnings call transcript

Advanced Drainage Systems, Inc. (NYSE:WMS ) Q2 2024 Earnings Conference Call November 2, 2023 10:00 AM ET Company Participants Mike Higgins – Vice P...

November 3, 2023, 10:57 pm

Modine manufacturing company (mod) q2 2024 earnings call transcript

Modine Manufacturing Company (NYSE:MOD ) Q2 2024 Earnings Conference Call November 2, 2023 11:00 AM ET Company Participants Kathy Powers – Vice Pres...

November 3, 2023, 10:53 pm


Search within

Pages Search Results: